OTCMKTS:CANSF Willow Biosciences (CANSF) Stock Price, News & Analysis → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free CANSF Stock Alerts $0.06 0.00 (0.00%) (As of 04/22/2024 ET) Add Compare Share Share Today's Range$0.06▼$0.0650-Day Range$0.06▼$0.1052-Week Range$0.05▼$0.11Volume2,500 shsAverage Volume25,498 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Get Willow Biosciences alerts: Email Address Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. About Willow Biosciences Stock (OTCMKTS:CANSF)Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company has a collaboration agreement with SUANFARMA to develop anti-infective API through precision fermentation. Willow Biosciences Inc. is headquartered in Calgary, Canada.Read More CANSF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CANSF Stock News HeadlinesApril 2, 2024 | markets.businessinsider.comCBG Producer Willow Biosciences Announces Record 43% Revenue Increase And Strategic Moves AheadApril 1, 2024 | proactiveinvestors.comWillow Biosciences expects first commercial revenues in 2024April 23, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. March 28, 2024 | finance.yahoo.comWILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIFMarch 28, 2024 | prnewswire.comWILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIFMarch 1, 2024 | proactiveinvestors.comWillow Biosciences unveils second strategic investment from KalsecFebruary 29, 2024 | prnewswire.comWILLOW BIOSCIENCES ANNOUNCES SECOND STRATEGIC INVESTMENT FROM KALSECFebruary 22, 2024 | finanznachrichten.deWillow Biosciences Inc.: Willow Biosciences Announces Strategic Investment From Kalsec To Develop Innovative Natural Food IngredientsApril 23, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. February 21, 2024 | proactiveinvestors.comWillow Biosciences unveils cash injection for natural ingredients developmentFebruary 20, 2024 | prnewswire.comWILLOW BIOSCIENCES ANNOUNCES STRATEGIC INVESTMENT FROM KALSEC TO DEVELOP INNOVATIVE NATURAL FOOD INGREDIENTSJanuary 31, 2024 | finance.yahoo.comWILLOW ANNOUNCES COLLABORATION WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP A MORE COST-EFFECTIVE, SUSTAINABLE PROCESS FOR A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENTJanuary 16, 2024 | finance.yahoo.comWILLOW ANNOUNCES COLLABORATION WITH ENTERIN TO DEVELOP SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTSJanuary 5, 2024 | theglobeandmail.comClosing Bell: Willow Biosciencesinc up on Friday (WLLW)November 14, 2023 | finance.yahoo.comWILLOW BIOSCIENCES REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATEOctober 12, 2023 | theguardian.comAustralian Fashion Laureate awards 2023: Kit X’s Kit Willow warns against ‘crazy’ overconsumptionOctober 10, 2023 | msn.comWillow Springs Garden Haunted Corn Mazes returnOctober 10, 2023 | msn.comSeven injured after taxi van crashes into building in Willow Lawn, driver chargedOctober 9, 2023 | msn.comPolice fatally shoot woman waving a gun at first responders in Willow GroveOctober 8, 2023 | msn.comBuffy The Vampire Slayer: Why Does Willow Turn Evil?October 6, 2023 | msn.comWillow Nightingale Wants To Inspire People Through Hard Work And AuthenticityOctober 6, 2023 | msn.comLafayette Police currently investigating hit and run fatality, West Willow Street closedOctober 5, 2023 | msn.comWillow Smith’s evolving style: From cool tween to stylish rock starOctober 5, 2023 | finance.yahoo.comWillow Bioscience teams again with Suanfarma on large volume anti-infective APIOctober 4, 2023 | msn.comWillow Smith shares stunning Earth, Wind, and Fire coverOctober 3, 2023 | proactiveinvestors.comWillow Biosciences partners Suanfarma to develop large volume anti-infective API through precision fermentationOctober 3, 2023 | finance.yahoo.comWILLOW AND SUANFARMA ANNOUNCE COLLABORATION ON DEVELOPMENT OF LARGE VOLUME ANTI-INFECTIVE API THROUGH PRECISION FERMENTATIONSee More Headlines Receive CANSF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Willow Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/23/2024Next Earnings (Estimated)5/06/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:CANSF CUSIPN/A CIKN/A Webwww.willowbio.com Phone(403) 910-5140FaxN/AEmployees32Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesDr. Chris SavilePresident, Director & CEOMr. Travis Doupe (Age 52)Chief Financial Officer Comp: $278.4kDr. Trish ChoudharySenior Vice President of Research & DevelopmentMr. Troy T. TalkkariVice President of Corporate DevelopmentMr. Sanjib Singh Gill L.L.B. (Age 48)Corporate Secretary Key Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All Competitors CANSF Stock Analysis - Frequently Asked Questions How have CANSF shares performed in 2024? Willow Biosciences' stock was trading at $0.0699 on January 1st, 2024. Since then, CANSF shares have decreased by 8.7% and is now trading at $0.0638. View the best growth stocks for 2024 here. Are investors shorting Willow Biosciences? Willow Biosciences saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 24,300 shares, an increase of 73.6% from the March 15th total of 14,000 shares. Based on an average daily volume of 26,200 shares, the days-to-cover ratio is presently 0.9 days. View Willow Biosciences' Short Interest. When is Willow Biosciences' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 6th 2024. View our CANSF earnings forecast. How do I buy shares of Willow Biosciences? Shares of CANSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:CANSF) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe #1 Crypto for 2024InvestorPlaceMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Willow Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
